| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |